Skip to main content
Log in

Evaluation of selective human MAO inhibitory activities of some novel pyrazoline derivatives

  • Translational Neurosciences - Original Article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Abstract

A series of 1-[2-((5-methyl/chloro)-2-benzoxazolinone-3-yl)acetyl]-3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives were prepared by reacting 2-((5-methyl/chloro)-2-benzoxazolinone-3-yl)acetylhydrazine with appropriate chalcones. The chemical structures of all compounds were confirmed by elemental analyses, IR, 1H NMR and ESI–MS. All the compounds were investigated for their ability to selectively inhibit monoamine oxidase (MAO) by in vitro tests. MAO activities of the compounds were compared with moclobemide and selegiline and all the compounds were found to inhibit human MAO-A selectively. The inhibition profile was found to be competitive and reversible for all compounds by in vitro tests. Among the compounds examined, compounds 5ae, 5af and 5ag were more selective than moclobemide, with respect to the K i values experimentally found. In addition, the compound 5bg showed MAO-A inhibitor activity as well as moclobemide. A series of experimentally tested compounds (5ae–5ch) were docked computationally to the active site of the MAO-A and MAO-B isoenzyme. The AUTODOCK 4.01 program was employed to perform automated molecular docking.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Fig. 1

Similar content being viewed by others

References

  • Anderson MC, Hasan F, McCrodden JM, Tipton KF (1993) Monoamine oxidase inhibitors and the cheese effect. Neurochem Res 18:1145–1149

    Article  PubMed  CAS  Google Scholar 

  • Bilgin AA, Palaska E, Sunal R (1993) Studies on the synthesis and antidepressant activity of Some 1-thiocarbamoyl-3,5-diphenyl-2-pyrazolines. Arzneimittel-Forsch 43:1041–1044

    CAS  Google Scholar 

  • Binda C, Wang J, Pisani L, Caccia C, Carotti A, Salvati P, Edmondson DE, Mattevi A (2007) Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J Med Chem 50:5848–5852

    Article  PubMed  CAS  Google Scholar 

  • Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254

    Article  PubMed  CAS  Google Scholar 

  • Çakır B, Dağ Ö, Yıldırım E, Erol K, Şahin MF (2001) Synthesis and anticonvulsant activity of some hydrazones of 2[(3H)-oxobenzoxazolin-3-yl-aceto]hydrazide. J Fac Pharm Gazi 18:99–106

    Google Scholar 

  • Chen SQ, Zhang YC, Liu FM (2011) Synthesis and spectral characterization of some new thiazolyl-pyrazolines bearing 1,2,4-triazole moiety. Phosphorus Sulfur 186:319–325

    Article  CAS  Google Scholar 

  • Chimenti F, Bolasco A, Manna F, Secci D, Chimenti P et al (2004) Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase. J Med Chem 47:2071–2074

    Article  PubMed  CAS  Google Scholar 

  • Chimenti F, Maccioni E, Secci D, Bolasco A, Chimenti P, Granese A et al (2005) Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-(1H)-pyrazole derivatives. J Med Chem 48:7113–7122

    Article  PubMed  CAS  Google Scholar 

  • Chimenti F, Bolasco A, Manna F, Secci D, Chimenti P, Granese A, Befani O, Turini P, Alcaro S, Ortuso F (2006a) Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors. Chem Biol Drug Des 67:206–214

    Article  PubMed  CAS  Google Scholar 

  • Chimenti F, Bolasco A, Manna F, Secci D, Chimenti P, Granesea A, Befani O, Turini P, Cirilli R et al (2006b) Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors. Curr Med Chem 13:1411–1428

    Article  PubMed  CAS  Google Scholar 

  • Chimenti F, Fioravanti R, Bolasco A, Manna F, Chimenti P et al (2007) Monoamine oxidase isoform-dependent tautomeric influence in the recognition of 3,5-diaryl pyrazole ınhibitors. J Med Chem 50:425–428

    Article  PubMed  CAS  Google Scholar 

  • Chimenti F, Fioravanti R, Bolasco A, Manna F, Chimenti P et al (2008a) Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives. Eur J Med Chem 43:2262–2267

    Article  PubMed  CAS  Google Scholar 

  • Chimenti F, Maccioni E, Secci D, Bolasco A, Chimenti P et al (2008b) Synthesis, stereochemical identification, and selective inhibitory activity against human monoamine oxidase-B of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones. J Med Chem 51:4874–4880

    Article  PubMed  CAS  Google Scholar 

  • Chimenti F, Carradori S, Secci D, Bolasco A, Bizzarri B et al (2010) Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives. Eur J Med Chem 45:800–804

    Article  PubMed  CAS  Google Scholar 

  • Close WJ, Tiffany BD, Spielman MA (1949) The analgesic activity of some benzoxazolone derivatives. J Am Chem Soc 71:1265–1268

    Article  PubMed  CAS  Google Scholar 

  • Dawey W, Tivey DJ (1958) Chalcones and related compounds. Part IV. Addition of hydrogen cyanide to chalcones 242:1230–1236

  • Dong F, Jian C, Zhenghao F, Kai G, Zuliang L (2008) Synthesis of chalcones via Claisen–Schmidt condensation reaction catalyzed by acyclic acidic ionic liquids. Catal Commun 9:1924–1927

    Article  Google Scholar 

  • Drukarch B, van Muiswinkel FL (2000) Drug treatment of Parkinson’s disease. Time for phase II. Biochem Pharmacol 59:1023–1031

    Article  PubMed  CAS  Google Scholar 

  • Gökçe M, Geciken AE, Yıldırım E, Tosun AU (2001) Synthesis and anticonvulsant activity of 5-chloro-2(3H)-benzoxazolinone-3-acetyl-2-(o/p-substituted benzal)hydrazone derivatives. Arzneimittelforschung 58:537–542

    Google Scholar 

  • Gökhan N, Yeşilada A, Uçar G, Erol K, Bilgin AA (2003) 1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: synthesis and evaluation as MAO inhibitors. Arch Pharm Pharm Med Chem 336:362–371

    Article  Google Scholar 

  • Gökhan-Kelekçi N, Yabanoğlu S, Küpeli E, Salgın U, Özgen Ö et al (2007) A new therapeutic approach in alzheimer disease: some novel pyrazole derivatives as dual MAO-B inhibitors and antiinflammatory analgesics. Bioorg Med Chem 15:5775–5786

    Article  PubMed  Google Scholar 

  • Gökhan-Kelekçi N, Koyunoğlu S, Yabanoğlu S, Yelekçi K, Özgen Ö et al (2009) New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. Bioorg Med Chem 17:675–689

    Article  PubMed  Google Scholar 

  • Holla BS, Akberali PM, Shivananda MK (2000) Studies on arylfuran derivatives-Part X. Synthesis and antibacterial properties of arylfuryl- 2-pyrazolines. Il Farmaco 55:256–263

    Article  PubMed  CAS  Google Scholar 

  • Irie K, Watanabe K (1980) Aldol condensations with metal(II) complex catalysts. Bull Chem Soc Jpn 53:1366–1371

    Article  CAS  Google Scholar 

  • Kubota Y, Ikeya H, Sugi Y, Yamada T, Tatsumi T (2006) Organic-inorganic hybrid catalysts based on ordered porous structures for Michael reaction. J Mol Catal A-Chem 249:181–190

    Article  CAS  Google Scholar 

  • Lipson VV, Desenko SM, Shirobokova MG, Borodina VV, Musatov VI (2005) Chemical reactions of 2-methyl-5,7-diphenyl-6,7-dihydropyrazolo[1,5-a]pyrimidine (New York, NY, United States). Chem Heterocycl Compd 41:492–495

    Article  CAS  Google Scholar 

  • Manna F, Chimenti F, Bolasco A, Secci D, Bizzarri B et al (2002) Inhibition of amine oxidases activity by 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives. Bioorg Med Chem Lett 12:3629–3633

    Article  PubMed  CAS  Google Scholar 

  • Milcent R, Akhnazarian A, Lensen N (1996) Synthesis of 1-(2-hydroxyphenyl)-2,4-imidazolidinedione derivatives through cyclic transformations of ethyl 2-oxo-3(2H)-benzoxazoleacetate derivatives. J Heterocycl Chem 33:1829–1833

    Article  CAS  Google Scholar 

  • Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) Autodock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comp Chem 16:2785–2791

    Article  Google Scholar 

  • Önkol T, Gökçe M, Tosun AU, Polat S, Serin MS, Tezcan S (2008) Microwave synthesis and antimicrobial evaluation of 5-chloro-2(3H)-benzoxazolinone-3-acetyl-2-(p-substituted benzal)hydrazone and 5-chloro-2(3H)-benzoxazolinone-3-acetyl-2-(p-substituted acetophenone)hydrazone derivatives. Turk J Pharm Sci 5:155–166

    Google Scholar 

  • Özdemir Z, Kandilci HB, Gümüşel B, Çalış Ü, Bilgin AA (2007) Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-furyl)-pyrazoline derivatives. Eur J Med Chem 42:373–379

    Article  PubMed  Google Scholar 

  • Özdemir Z, Kandilci HB, Gümüşel B, Çalış Ü, Bilgin AA (2008) Synthesis and studies on antidepressant and anticonvulsant activities of some 3-(2-thienyl)-pyrazoline derivatives. Arch Pharm Chem Life Sci 341:701–707

    Article  Google Scholar 

  • Palaska E, Aytemir M, Uzbay İT, Erol D (2001) Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines. Eur J Med Chem 36:539–543

    Article  PubMed  CAS  Google Scholar 

  • Palaska E, Aydın F, Uçar G, Erol D (2008) Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives. Arch Pharm Chem Life Sci 341:209–215

    Article  CAS  Google Scholar 

  • Potts KT, Bhattacharjee D, Kanemasa S (1980) Mesoionic compounds. 52. Attempted synthesis of the anhydro-2-hydroxyoxazolo[2,3b-]oxazolium hydroxide system. J Org Chem 45:4985–4988

    Article  CAS  Google Scholar 

  • Şahin ZS, Salgın-Gökşen U, Gökhan-Kelekçi N, Işık Ş (2011) Synthesis, crystal structures and DFT studies of 1-[2-(5-methyl-2-benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole and 1-[2-(5-chloro-2-benzoxazolinone-3-yl)acetyl]-3-phenyl-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazole. J Mol Struct 1006:147–158

    Google Scholar 

  • Salgın-Gökşen U, Gökhan-Kelekçi N, Göktaş Ö, Köysal Y, Kılıç E et al (2007) 1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: synthesis, analgesic-anti-inflammatory and antimicrobial activities. Bioorg Med Chem 15:5738–5751

    Article  PubMed  Google Scholar 

  • Sarabhai KP, Mathur KBL (1963) Some arylation reactions with diazotized 3,4,5-trimethoxyaniline. Preparation of 3,4,5-trimethoxychalcone and 3,4,5-trimethoxybenzaldehyde. Indian J Chem 1:482–483

    CAS  Google Scholar 

  • Schapira AH (2007) Treatment options in the modern management of Parkinson disease. Arch Neurol 64:1083–1088

    Article  PubMed  Google Scholar 

  • Secci D, Bolasco A, Chimenti P, Carradori S (2011) The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant/anticonvulsant agents. Curr Med Chem 18:5114–5144

    Article  PubMed  CAS  Google Scholar 

  • Shekarchi M, Pirali-Hamedani M, Navidpour L, Adib N, Shafiee A (2008) Synthesis, antibacterial and antifungal activities of 3-aryl-5-(pyridin-3-yl)-4,5-dihydropyrazole-1-carbothioamide derivatives. J Iran Chem Soc 5:150–158

    Article  CAS  Google Scholar 

  • Son S-Y, Ma J, Kondou Y, Yoshimura M, Yamashita E, Tsukihara T (2008) Structure of human monoamine oxidase A at 2.2-Å resolution: the control of opening the entry for substrates/inhibitors. P Natl Acad Sci USA 105:5739–5744

    Article  CAS  Google Scholar 

  • Ueno Y, Yadav LDS, Okawara M (1983) Carbon-carbon bond formation via phosphine-initiated cleavage of oxosulphides. Chem Lett 6:831–834

    Article  Google Scholar 

  • Ünlü S, Erdoğan H, Sunal R (1992) Synthesis of some (2-benzoxazolinones-3-yl)alkonoic acid derivatives and their analgesic properties. Hacettepe University J Faculty of Pharm 12:23–31

    Google Scholar 

  • Yamada M, Yasuhara H (2004) Clinical pharmacology of MAO inhibitors: safety and future. Neurotoxicology 25:215–221

    Article  PubMed  CAS  Google Scholar 

  • Yáñez M, Fraiz N, Cano E, Orallo F (2006) Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity. Biochem Biophys Res Commun 344:688–695

    Article  PubMed  Google Scholar 

  • Yelekçi K, Karahan Ö, Toprakci M (2007) Docking of novel reversible monoamine oxidase-B inhibitors: efficient prediction of ligand binding sites and estimation of inhibitors thermodynamic properties. J Neural Transm 114:725–732

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gülberk Uçar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salgın-Gökşen, U., Yabanoğlu-Çiftçi, S., Ercan, A. et al. Evaluation of selective human MAO inhibitory activities of some novel pyrazoline derivatives. J Neural Transm 120, 863–873 (2013). https://doi.org/10.1007/s00702-013-0980-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-013-0980-6

Keywords

Navigation